ArticleBasic research in cardiology2024

Empagliflozin prevents heart failure through inhibition of the NHE1-NO pathway, independent of SGLT2.

Sha Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.